MWNA
MGNX icon

Marshall Wace North America’s MacroGenics MGNX Stock Holding History

Marshall Wace North America’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-36,256
Closed -$830K – 1671
2020
Q4 		$830K Buy
+36,256
New +$835K ﹤0.01% 984
2019
Q2 		– Sell
-3,260
Closed -$59K – 1419
2019
Q1 		$59K Buy
+3,260
New +$56.4K ﹤0.01% 1235
2018
Q2 		– Sell
-58,820
Closed -$1.48M – 1566
2018
Q1 		$1.48M Buy
+58,820
New +$1.43M 0.01% 904
2017
Q3 		– Sell
-81,879
Closed -$1.47M – 1410
2017
Q2 		$1.47M Sell
81,879
-155,686
-66% -$2.97M 0.01% 827
2017
Q1 		$4.51M Buy
+237,565
New +$4.58M 0.04% 412
2013
Q4 		$233K Buy
+8,500
New +$222K ﹤0.01% 624

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Marshall Wace North America's MGNX Position: Q1 2021 in Review

Marshall Wace North America sold out of MacroGenics (MGNX) in Q1 2021, closing a stake of 36,256 shares — an estimated $830K sold.

Marshall Wace North America first reported a position in MGNX in Q4 2013 and held it in 6 quarters. The position peaked at $4.51M in Q1 2017. 173 funds tracked by Wall St. Rank hold MGNX as of Q1 2021.

  • Marshall Wace North America reported no remaining MacroGenics position as of Q1 2021 after selling out during the quarter.
  • Marshall Wace North America sold 36,256 MacroGenics shares in Q1 2021, an estimated $830K.
  • Marshall Wace North America first reported a position in MacroGenics in Q4 2013 and held it in 6 quarters.
  • Marshall Wace North America's MacroGenics position peaked at $4.51M in Q1 2017.
  • 173 funds tracked by Wall St. Rank held MacroGenics as of Q1 2021.

Based on Marshall Wace North America's 13F filing for Q1 2021, filed 17 May 2021.